MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$4,461,895
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Depreciation
0 0* 0 0
Research and development
2,745,945 340,185.5* 2,192,881 2,499,495
General and administrative
1,748,239 1,083,917.5* 1,153,032 2,182,289
Total operating expenses
4,494,184 1,424,103 3,345,913 4,681,784
Operating loss
-4,494,184 -1,424,103* -3,345,913 -4,681,784
Other income
31,748 12,971* 2,405 6,881
Other financing costs
-2,106,582* -455,549 -
Realized and unrealized gain (loss)
541 -27.5* -183 2
Net loss
-4,461,895 -3,517,741.5* -3,799,240 -4,674,901
Deemed dividend related to warrant modification
-0* 0 0
Net loss attributable to common stockholders
--3,517,741.5 -3,799,240 -4,674,901
Basic EPS
-0.64 -3.771 -5 -0.17
Basic Average Shares
6,951,999 932,730* 760,502 27,593,952
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$4,461,895 Other income$31,748 Realized and unrealizedgain (loss)$541 Operating loss-$4,494,184 Total operatingexpenses$4,494,184 Research and development$2,745,945 General andadministrative$1,748,239

Genprex, Inc. (GNPX)

Genprex, Inc. (GNPX)